MPT — Medical Properties Trust, Inc. stock price, charts and financials

QT41Medical Properties Trust, Inc.

Medical Properties Trust, Inc. (NYSE: MPT) is a Real Estate company in the REIT - Healthcare Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
4.65
+0.06+1.31%
OverviewShort InterestFilings
MPTQT41Medical Properties Trust, Inc.·NYSE
4.65+1.31%
TA
Loading chart...
Signal & projected range
Short-squeeze setupHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.
Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
MPW+0.00%$5.50NHI-1.82%$74.56DHC-0.11%$8.80LTC-1.11%$38.48SILA+0.00%$30.36SBRA+0.24%$20.66HR-1.31%$20.27CTRE-0.92%$40.84
Snapshot
Index-P/E-EPS (ttm)-0.21Insider Own2.85%Shs Outstand598.10MPerf Week-3.73%
Market Cap2.78BForward P/E39.05EPS next Y0.12Insider Trans0.00%Shs Float490.65MPerf Month0.87%
Enterprise Value12.12BPEG-EPS next Q-Inst Own-Short Float28.17%Perf Quarter-6.44%
Income-126.00MP/S2.78EPS this Y163.31%Inst Trans-Short Ratio23.40Perf Half Y-9.53%
Sales1.00BP/B0.61EPS next Y-10.42%ROA-0.85%Short Interest138.23MPerf YTD-7.00%
Book/sh7.60P/C6.54EPS next 5Y-ROE-2.70%52W High6.47 -28.13%Perf Year14.53%
Cash/sh0.71P/FCF12.81EPS past 3/5Y-ROIC4.12%52W Low3.95 17.72%Perf 3Y-53.73%
Dividend Est.0.36 (7.74%)EV/EBITDA12.80Sales past 3/5Y-14.28% -4.89%Gross Margin96.07%Volatility2.43% 2.76%Perf 5Y-77.71%
Dividend TTM0.35 (7.53%)EV/Sales12.12EPS Y/Y TTM94.78%Oper. Margin56.95%ATR (14)0.13Perf 10Y-70.42%
Dividend Ex-DateJun 18, 2026Quick Ratio11.12Sales Y/Y TTM0.40%Profit Margin-12.59%RSI (14)46.01Recom2.75
Dividend Gr. 3/5Y-34.23% -21.11%Current Ratio11.12EPS Q/Q-61.29%SMA20-1.01%Beta1.45Target Price11.27
Payout-159.15%Debt/Eq2.13Sales Q/Q12.50%SMA50-2.37%Rel Volume0.94Prev Close4.59
Employees121LT Debt/Eq1.99EarningsAug 10SMA200-8.12%Avg Volume5.79MPrice4.65
IPO DateJul 07, 2005Option/ShortYes / YesEPS/Sales Surpr.97.09% 4.32%Net Debt/EBITDA9.86Volume5,467,656Change1.31%
Analyst Ratings
DateActionAnalystRatingTarget
Feb-03-26InitiatedMaximBuy$8.00
Nov-25-25ReiteratedWells FargoUnderweight$7.50 → $5.00
Mar-12-25UpgradeExane BNP ParibasNeutral → Outperform
Mar-11-25ReiteratedBNP Paribas$4.00 → $9.00
Sep-13-24UpgradeColliers SecuritiesNeutral → Buy$6.50
Sep-13-24ReiteratedTruist SecuritiesHold$8.00 → $6.00
Sep-12-24ReiteratedMizuho SecuritiesNeutral$7.00
Aug-02-24ReiteratedWells FargoUnderweight$7.50
Aug-02-24ReiteratedTruist FinancialHold$5.00 → $8.00
Jul-02-24DowngradeExane BNP ParibasOutperform → Neutral
Latest News
Jul-29-26
Jul-29-2608:00AM
MPT Announces Second Quarter 2026 Financial Results Conference Call and Webcastbusinesswire.com
Jul-28-26
Jul-28-2609:15AM
2 Plunging 6-12% Yields: Only One Belongs In A Retirement PortfolioSeekingAlpha
Jul-20-26
Jul-20-2607:15AM
Sell Alert: 3 REITs Facing Likely Dividend CutsSeekingAlpha
Jul-12-26
Jul-12-2609:30AM
My 4 Worst REIT Picks: Lessons Learned The Hard WaySeekingAlpha
Jul-09-26
Jul-09-2606:03PM
Why I'm Buying Healthcare REITs Before Wall Street DoesSeekingAlpha
Jul-08-26
Jul-08-2608:00AM
Medical Properties Trust Announces Infracore Swiss Listingbusinesswire.com
Jun-23-26
Jun-23-2604:42PM
Medical Properties Trust's Tenant And Balance Sheet Risks Remain: A Contrarian Dividend StorySeekingAlpha
Jun-22-26
Jun-22-2608:13AM
Medical Properties: Strong Recovery PotentialSeekingAlpha
Jun-19-26
Jun-19-2610:45AM
U.S. Equity REIT Average Short Interest Edges Higher In MaySeekingAlpha
Jun-18-26
Jun-18-2609:57AM
RBC Capital Maintains Sector Perform on Medical Properties Trust, Lowers Price Target to $4.5Benzinga
Jun-17-26
Jun-17-2612:53PM
Bloom Energy and M-tron have been highlighted as Zacks Bull and Bear of the DayYahoo
Jun-16-26
Jun-16-2612:34PM
Hewlett Packard and M-tron have been highlighted as Zacks Bull and Bear of the DayYahoo
08:00AM
Bear of the Day: M-tron Industries (MPTI)Yahoo
Company

Medical Properties Trust, Inc. functions as a self-managed real estate investment trust (REIT). The company specializes in the financing, acquisition, and construction of healthcare properties, all structured under net-lease agreements. Its extensive property holdings encompass a diverse array of medical establishments, such as rehabilitation centers, extended-stay acute care hospitals, outpatient surgical facilities, hospitals catering to women and children, community and regional general hospitals, medical office complexes, and various other specialized care sites. The trust was established in 2003 by its co-founders, Edward K. Aldag Jr., R. Steven Hamner, Emmett E. McLean, and William Gilliard McKenzie, with its principal offices situated in Birmingham, Alabama.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue1,0009729968721,5431,5451,249870785
Cost of Goods Sold Incl. D&A40362742463925249
Gross Profit9619369688301,4971,5061,224846775
Selling, General and Administrative Excl. Other1211301341461601461329681
Research and Development
000000000
Other Operating Expense2712664476033333211,0920694
Operating Income570540387811,0041,0390750561
Interest Expense641510422411368395357238223
Unusual Expense
—————————
Non-Operating Income (Expense)-58-267-2,329-35732587820-138681
Net Income Before Taxes-129-237-2,364-6879607314633741,019
Income Taxes-33944-131567431-31
Consolidated Net Income-126-277-2,410-5569036564313751,017
Net Income From Continuing Operations-124-276-2,408-5569046574323761,018
Net Income-126-277-2,410-5569036564313751,017
EPS (Recurring)-0.21-0.46-4.02-0.931.501.110.810.872.77
EPS (Basic, Before Extraordinaries)-0.21-0.46-4.02-0.931.501.110.810.872.77
EPS (Diluted)-0.21-0.46-4.02-0.931.501.110.810.872.76
EBITDA947546-1,4883401,6741,4601,104754703
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio————7.4321.2926.9024.265.83
Price To Sales Ratio2.783.092.383.374.329.019.2310.367.48
Gross Margin96.1096.3097.1995.1897.0297.4898.0097.2498.73
Operating Margin57.0055.5638.869.2965.0767.250.0086.2171.46
Net Margin-12.60-28.50-241.97-63.7658.5242.4634.5143.10129.55
Shares Outstanding598601600599599589529427365
Market Capitalization2,7813,0052,3702,9416,67313,91811,5279,0145,869
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$6.33$5.66$5.00$4.34$3.67● Close Price0.00K74.05K148.09K222.13K296.18KUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Hooper Rosa HandleySVP of OperationsDec 15 '25Sale5.002,00010,000395,182Dec 16
Stewart Michael GDirectorNov 19 '25Sale5.0259,000296,180157,100Nov 21
Stewart Michael GDirectorMay 05 '25Sale5.2029,000150,800216,100May 05
Hanna James KevinSenior VP, Controller & CAOMar 05 '25Buy5.757,41142,613372,338Mar 06
Hanna James KevinSenior VP, Controller & CAODec 26 '24Sale3.7211,64143,305366,913Dec 26
Hooper Rosa HandleySVP of OperationsDec 23 '24Sale3.673,00011,010356,600Dec 26
Stewart Michael GDirectorOct 09 '24Sale5.4632,780178,979221,245Oct 09
Pitman Elizabeth NDirectorSep 18 '24Buy6.018,08748,60376,740Sep 19
THOMPSON C REYNOLDS IIIDirectorAug 27 '24Sale4.3820,53089,92154,637Aug 27
Pitman Elizabeth NDirectorAug 15 '24Sale4.9810,02549,92568,653Aug 15
HAMNER R STEVENExecutive Vice President & CFOApr 07 '22Sale21.04285,0005,996,4001,961,214Apr 08
Aldag Edward K JRChairman, President & CEOMar 30 '22Sale21.33615,00013,117,9503,497,206Apr 01
Stewart Michael Gdirector:Mar 10 '22Sale20.266,000121,560214,436Mar 10
Stewart Michael GDirectorAug 02 '21Sale20.884,800100,224214,884Aug 03
Aldag Edward K JRChairman, President & CEOMar 30 '21Sale21.21710,00015,059,1003,251,167Mar 31
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.